BBSRC invests £48m in Babraham Institute to advance lifelong health research The funding will help to support research across epigenetics, immunology and cell signalling
Novo Nordisk to open new AI hub in UK for drug discovery The new hub will be located in the King’s Cross Knowledge Quarter, London